title: Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patients.
authors.affiliation: Pediatric oncology department, Institut Curie, Paris, France.
authors.forename: J M
authors.initials: JM
authors.lastname: Zucker
authors.forename: T
authors.initials: T
authors.lastname: Philip
authors.forename: J L
authors.initials: JL
authors.lastname: Bernard
authors.forename: J
authors.initials: J
authors.lastname: Michon
authors.forename: E
authors.initials: E
authors.lastname: Bouffet
authors.forename: J C
authors.initials: JC
authors.lastname: Gentet
authors.forename: M
authors.initials: M
authors.lastname: Lopez
authors.forename: C
authors.initials: C
authors.lastname: Coze
authors.forename: I
authors.initials: I
authors.lastname: Philip
authors.forename: P
authors.initials: P
authors.lastname: Bordigoni
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002675:Child, Preschool; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D011336:Probability; D011379:Prognosis
chemical_list: D016178:Granulocyte-Macrophage Colony-Stimulating Factor